$2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

New Peoples Bankshares

• The Trade: New Peoples Bankshares, Inc. NWPP Director John D Cox acquired a total of 40,000 shares an average price of $2.50. To acquire these shares, it cost around $100,000.
• What’s Happening: The company’s shares fell around 13% over the past month.
• What New Peoples Bankshares Does: New Peoples Bankshares Inc is a bank holding company for New Peoples Bank.

Socket Mobile

• The Trade: Socket Mobile Inc SCKT Director Charlie Bass acquired a total of 5,000 shares at an average price of $1.08. To acquire these shares, it cost around $5,400.
• What’s Happening: Socket Mobile posted a wider-than-expected third-quarter loss.
• What Socket Mobile Does: Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education.

Check This Out: Teradata Likely To Report Higher Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Repare Therapeutics

• The Trade: Repare Therapeutics Inc. RPTX 10% owner Mark Lampert acquired a total of 783,709 shares at an average price of $3.60. The insider spent around $2.82 million to buy those shares.
• What’s Happening: Repare Therapeutics posted a narrower-than-expected loss for its second quarter.
• What Repare Therapeutics Does: Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer.

Lumen Technologies

• The Trade: Lumen Technologies, Inc. LUMN President and CEO Kathleen E Johnson acquired a total of 1,000,000 shares at an average price of $0.97. The insider spent around 970,000 to buy those shares. The company’s EVP and CFO also bought 500,000 shares.
• What’s Happening: Lumen Technologies reported mixed third-quarter results. The company also announced an agreement with creditors.

What Lumen Technologies Does: With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises.

Don’t forget to check out our premarket coverage here